Krishna Madhavan

2PUBLICATIONS
20CO-AUTHORS
Gene and molecular therapyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 27, 2025
Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma.

Ilango Balakrishnan, Krishna Madhavan, Angela Pierce

|Mar 28, 2022
Venetoclax Cooperates with Ionizing Radiation to Attenuate Diffuse Midline Glioma Tumor Growth.

Krishna Madhavan, Ilango Balakrishnan, Senthilnath Lakshmanachetty

Pageof 1